BioCentury
ARTICLE | Company News

ProStrakan, Bayer deal

December 8, 2008 8:00 AM UTC

Bayer's Bayer Schering Pharma AG subsidiary received an exclusive license to develop and commercialize ProStrakan's Tostran testosterone gel to treat male hypogonadism in Canada, Latin America, the ...